Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy.

Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy. Abstract Text:

Mairead Heaney,Yvonne Looney,Caleb McKinstry,Brendan O'Hare,Mairead Heaney,Yvonne Looney,Caleb McKinstry,Brendan O'Hare,

BACKGROUND: Tonsillectomy is a common pediatric surgical procedure resulting in significant postoperative pain. There is ongoing controversy as to the most satisfactory analgesic regimen. Nonsteroidal antiinflammatory drugs (NSAIDs) are an alternative to opioids in this setting. NSAID use in tonsillectomy has been shown to be opioid sparing in the recovery period and to have similar analgesic effects to opioids in pediatric patients. Because of their nonspecific action on the enzyme cyclo-oxygenase there is potential for increased bleeding which has led many practitioners to avoid NSAIDs completely in this patient population potentially resulting in suboptimal pain control. Our aim in this study was to assess the effect of preoperatively administered diclofenac on the blood clot strength in children undergoing (adeno-) tonsillectomy. METHODS: Twenty patients undergoing (adeno-) tonsillectomy were recruited into this prospective observational study. All patients received 2 mg.kg(-1) of diclofenac rectally immediately preoperatively. Blood was taken for thromboelastograph analysis pre-diclofenac and 1 and 4 h post-diclofenac administration. RESULTS: There was a statistically significant increase in maximal clot strength (MA) at 1 and 4 h after diclofenac. Similarly there was a statistically significant reduction in time to initial fibrin formation (R time) post-diclofenac. There was no primary or secondary hemorrhage. CONCLUSIONS: Diclofenac when given preoperatively does not adversely affect clot strength in the immediate postoperative period when the risk of primary hemorrhage is greatest.

Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy. Publishing Authors By Initials

M Heaney,Y Looney,C McKinstry,B O'Hare,M Heaney,Y Looney,C McKinstry,B O'Hare,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Paediatric anaesthesia

VOLUME: 17

Page Numbers: 1078-82

Journal Abbreviation:

ISSN: 1155-5645

DAY: 27

MONTH: Nov

YEAR: 2007

Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9206575

Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy.

AFFILIATION: Department of Anaesthesia and Critical Care Medicine, Our Lady's Hospital for Sick Children, Crumlin, Dublin, Ireland.

Country: France

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Paediatr Anaesth

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy Related Publications

• Age of onset and outcome in Landau-Kleffner syndrome (1985).
• Anatomy of the ward round.
• Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
• Developing a tissue perfusion sensor.
• Harm reduction in the Mersey Region.
• Identification of a highly conserved, functional nuclear localization signal within the N-terminal region of herpes simplex virus type 1 VP1-2 tegument protein.
• Improving access to Mental Health Review Tribunals.
• Individually addressable microelectrode array for monitoring oxygen and nitric oxide release.
• Letter from ireland 2007.
• Maintaining standards for pressure ulcer management in care homes.
• Merseyside, the first harm reduction conferences, and the early history of harm reduction.
• Mothers' experiences of facilitated peer support groups and individual child health nursing support: a comparative evaluation.
• Nuclear pore composition and gating in herpes simplex virus-infected cells.
• Racial differences in end-stage renal disease rates in HIV infection versus diabetes.
• Scaling in nonstationary voltammetry representations.
• Sequential clot strength analyses following diclofenac in pediatric adenotonsillectomy.
• Subacute bacterial endocarditis in pregnancy.
• Synapse-specific changes in serotonin signalling contribute to age-related changes in the feeding behaviour of the pond snail, Lymnaea.
• Synthesis, morphology, structure, and magnetic characterization of layered cobalt hydroxyisocyanates.
• Synthesis, structure, and characterization of a new thorium-organic framework material, Th(3)F(5)[(C(10)H(14))(CH(2)CO(2))(2)](3)(NO(3)).
• TOF-2: A Large 1D Channel Thorium Organic Framework.
• The expression patterns of integrin subunits on human breast tissues obtained during pregnancy.
• The impact of HIV on chronic kidney disease outcomes.
• The undergraduate and postgraduate teaching of geriatirc medicine.
• Thiazolidinediones and the renal and hormonal response to water immersion-induced volume expansion in type 2 diabetes mellitus.
• Trafficking of the bZIP Transmembrane Transcription Factor CREB-H into Alternate Pathways of ERAD and Stress-Regulated Intramembrane Proteolysis.
• Transmembrane bZIP transcription factors in ER stress signaling and the unfolded protein response.
• [(CH3)2NH(CH2)2NH(CH3)2][(UO2)2F2(HPO4)2]: a new organically templated layered uranium phosphate fluoride--synthesis, structure, characterization, and ion-exchange reactions.
• [(Th2F5)(NC7H5O4)2(H2O)][NO3]: an actinide-organic open framework.